[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$bms Graphic](https://lunarcrush.com/gi/w:26/t:$bms.png) $bms

$bms sees positive sentiment with FDA approval, but faces economic headwinds. Social media engagement is down, indicating potential price instability ahead.

### About $bms
Analysis of social media activity related to $bms, likely a stock ticker.  

### Insights [#](/topic/$bms/insights)
- $bms engagements is up XXXXXX% from the previous week.

### Engagements: XX [#](/topic/$bms/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$bms/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$bms/time-series/interactions.tsv)  
**Current Value**: XX  
**Daily Average**: XXX  
**1 Week**: XXXXX +660%  
**1 Month**: XXXXX -XX%  
**1-Year High**: XXXXX on 2025-08-24  
**1-Year Low**: X on 2025-06-27  

| Social Network | X  |
| -------------- | -  |
| Engagements    | XX |
  

  
  
### Mentions: X [#](/topic/$bms/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$bms/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$bms/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: X  
**1-Year High**: XX on 2025-07-21  
**1-Year Low**: X on 2025-06-23  

| Social Network | X |
| -------------- | - |
| Mentions       | X |
  

  
  
### Creators: X [#](/topic/$bms/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$bms/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$bms/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $bms in the last XX hours which is up XXX% from X in the previous XX hours
**Daily Average**: X  
**1-Year High**: XX on 2025-08-30  
**1-Year Low**: X on 2025-04-30  

**Top assets mentioned**
In the posts about $bms in the last XX hours

[Merck & Co., Inc. (MRK)](/topic/$mrk)

**Top topics mentioned**
In the posts about $bms in the last XX hours

[combo](/topic/combo), [$mrk](/topic/$mrk), [$nwbo](/topic/$nwbo), [stocks healthcare](/topic/stocks-healthcare), [$evtc](/topic/$evtc), [$evtde](/topic/$evtde), [loaded](/topic/loaded), [$bcrx](/topic/$bcrx), [$atxs](/topic/$atxs), [$700m](/topic/$700m), [$13sh](/topic/$13sh)

### Top Social Posts [#](/topic/$bms/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"📢 M&A News: BioCryst $BCRX to Acquire Astria Therapeutics $ATXS 💵 Cash-and-stock deal valued at about $700m 📈 $13/sh (53% premium over ATXS last close) 💉 Adds navenibart long-acting injectable for HAE currently in Ph3 🤝 To close in Q1 2026 See image for more info 👇"  
[X Link](https://x.com/BiopharmIQ/status/1978111044066111699) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-14T14:49Z 27.4K followers, 5357 engagements


"$NWBO Anthony Wang gave a presentation on early findings of the trial on using DCs loaded with peptides derived from H3 G34 to treat DHG. Systemic oligoclonal anti-tumor cytotoxic T cell response was observed in the trial. Recall what happened to the combo trial after keytruda was added to the combination of DCVax-L plus poly-iclc. No doubt adding two checking point inhibitors Nivolumab and Ipilimumab to the current combination in treating DHG should deliver blockbuster results. Clearly Merck would not let this trial proceed. A systemic oligoclonal anti-tumor cytotoxic T cell response is a"  
[X Link](https://x.com/d_stock07734/status/1977925855734358331) [@d_stock07734](/creator/x/d_stock07734) 2025-10-14T02:34Z XXX followers, 3608 engagements


"The Disappearing Combo How a withdrawn trial at #UCLA revealed the quiet architecture connecting $BMS $MRK and $NWBO and the people who taught the immune system to remember Prologue The Vanished Trial The notice appeared without ceremony. A single line on described a new study at UCLAs Jonsson Comprehensive Cancer Center. Patients with lethal brain tumors would receive two of Bristol Myers Squibbs most famous checkpoint inhibitorsYervoy (ipilimumab) and Opdivo (nivolumab)alongside a dendritic-cell vaccine made from their own tumors. It was small careful and quietly revolutionary: acceleration"  
[X Link](https://x.com/andrewcaravello/status/1977918273191661711) [@andrewcaravello](/creator/x/andrewcaravello) 2025-10-14T02:03Z 1265 followers, 4091 engagements


"$EVTC $BMS Evotec SE H1 2025 revenues fall XXX% to 371.2M reiterates full-year guidance"  
[X Link](https://x.com/byul_finance/status/1955590216133337505) [@byul_finance](/creator/x/byul_finance) 2025-08-13T11:20Z XXX followers, XXX engagements